Vagal Paraganglia Bind Biotinylated Interleukin-1 Receptor Antagonist: A Possible Mechanism for Immune-to-Brain Communication
Introduction
Tissue damage and exposure to pathogens such as viruses or bacteria leads to activation of the immune system. As part of the normal immune response, activated macrophages release proinflammatory cytokines such as interleukin-1β (IL1β) [[18]]. IL1β is important in attracting, activating, and orchestrating the subsequent response of other immune cells [[39]]. In addition, IL1β is a key mediator of immune-to-brain communication [29, 36 43[60]]. Peripherally administered IL1β and endotoxin [lipo-polysaccharide (LPS); constituents of the outer cell walls of gram negative bacteria which induce release of IL1β from activated immune cells] cause a variety of “illness” responses mediated by the central nervous system, including fever, hyperalgesia, conditioned taste aversion, decreased food intake, decreased social interaction, alterations in brain monoamine levels, and activation of the hypothalamic-pituitary-adrenal axis [29, 36, 43, 60]. Illness responses produced by both IL1β and LPS are blocked by peripheral administration of recombinant human IL1 receptor antagonist (rhIL1ra) [43, 60], supporting the conclusion that specific IL1 receptors are critical to the effects observed.
Although the pathways by which IL1β signals the brain have not been conclusively identified (for review, see [[60]]), strong empirical support is mounting for an afferent pathway via peripheral nerves, most notably the vagus. Subdiaphragmatic vagotomy decreases the strength of conditioned taste aversions [[26]] and blocks fever [55, 59], hyperalgesia [61, 62], hypothalamic norepinephrine depletion [[22]], and elevated plasma corticosteroid levels [[22]] produced by peripheral LPS or IL1β. In addition, subdiaphragmatic vagotomy blocks IP LPS-induced decreased social interaction [[8]], decreased food intake [[9]], increased ACTH release [[25]], increased brain levels of mRNA for IL1 [[41]], and increased c-Fos expression in the brain [25, 58].
The effects of vagotomy appear to be selective for responses to peripheral proinflammatory cytokines, such as IL1β, mediated by the central nervous system. Vagotomy does not alter any of the following measures, compared to controls: peripheral immune responses [8, 41], brain c-Fos activation to electric shock [[58]], serum corticosteroid elevation to tailshock [[42]], alterations in positive or negative acute phase proteins to tailshock [[42]], generation of fever in response to centrally administered prostaglandin [[42]], or acquisition of conditioned taste aversions to intragastric copper or alcohol (see [[26]] for review). Such findings support the conclusion that a generalized suppression of central or peripheral responsivity cannot underlie the dramatic effects of subdiaphragmatic vagotomy on a host of illness responses. Rather, they strengthen the hypothesis that immune-to-brain communication is mediated by activation of afferent vagal nerves.
One mechanism by which this immune-to-brain communication could occur may be binding of IL1 to sensory elements of the vagus nerve. Of particular note are glomus cells of paraganglia, which form afferent synapses with the vagus [2, 3, 52]. Paraganglia are found in all major branches of the vagus nerve [40, 45, 51, 52]. Some paraganglia are embedded within the vagus nerve, whereas other, often larger, encapsulated paraganglia are situated apart from the main trunks of the vagus, and are connected to it via small fascicles of afferent nerves [2, 17]. Paraganglia consist primarily of glomus cells, although about 10% of abdominal paraganglia also contain a few neurons of unknown function [[2]]. Although the function or functions of paraganglia are unknown, they have been proposed to serve a chemoreceptive function [[45]] and so are well-suited as an intermediary between substances released by activated immune cells and afferent activation of the vagus.
In the present study, we used a biotinylated form of interleukin 1 receptor antagonist (bIL1ra), an endogenous cytokine that binds to IL1 receptors [[20]], as an anatomical tool to detect the presence of binding sites on sensory elements of the vagus. Biotinylation of an endogenous IL1 receptor antagonist provides a new method for examining the distribution of IL1 binding sites. Both types of IL1 receptors would be expected to be detected by this technique, because IL1ra binds both type I and type II receptors [[20]]. Because IL1ra is produced using recombinant technology (Amgen), sufficient quantities are available to allow biotinylation of rhIL1ra to be a practical method for anatomical studies. This new technique avoids the need to use iodine-125-labeled cytokines [38, 56, 57], and provides greater cellular resolution (e.g., enabling one to distinguish between labeled perineureum cells vs. nerve fibers) than either binding assays [38, 56, 57] or in situ hybridization [[15]]. This is particularly important when studying peripheral tissues, where a number of cell types express IL1 receptors that may be difficult to distinguish using autoradiographic techniques.
Section snippets
IL1ra Biotinylation
Recombinant human IL1ra (Amgen) was biotinylated (bIL1ra) by Amgen by reacting a ratio of 12:1 biotin:IL1ra using kit #NHS-LC-Biotin (Pierce), according to manufacturer's instructions. bIL1ra binding to the type I soluble IL1 receptor was assayed by Amgen by surface plasmon resonance detection using a biospecific interaction analysis instrument (BIAcore; Pharmacia Biosensor AB). The BIAcore system measures interactions between macromolecules in real time [[35]] and is described in detail by
Results
Binding of bIL1ra occurred in some connective tissue fibrils, blood vessels (Fig. 2e) occasionally in unidentified cells of apparently reticuloendothelial derivation (possibly mast cells and/or macrophages) and in lymphoid tissues including lymph duct wall. In sections of hepatic vagus nerve, bIL1ra occasionally bound to perineurium, but not to nerve fibers. In addition, a subpopulation of glomus cells in the paraganglia associated with all three (cervical/laryngeal, thoracic, and
Discussion
The results of this study demonstrate that glomus cells of paraganglia associated with subdiaphragmatic, cervical/laryngeal, and thoracic vagus express binding sites for bIL1ra. Given their anatomical distribution and their afferent synaptic connections to vagal terminals [4, 45], these paraganglia are strategically located to detect local increases in tissue IL1β along the course of vagal branches and to relay this information to the brain. Such an action provides a potential explanation for
Acknowledgements
This work was supported by NIH Grant NS31569, NIH Grant MH55283, the Hughes Undergraduate Research Initiative, the Undergraduate Research Opportunities Program, and Amgen. Special thanks are due to Dr. R. P. A. Gaykema (Vrie Universiteit, Amsterdam) for providing TH-stained sections of vagus nerve and paraganglia.
References (62)
- et al.
Brain interleukin 1 gene expression induced by peripheral lipopolysaccharide administration
Cytokine
(1992) - et al.
Lipopolysaccharide and interleukin-1 depress feeding behavior in mice by a vagal-mediated mechanism
Brain Behav. Immunol.
(1995) - et al.
Characterization of type A and type B CCK receptor binding sites in rat vagus nerve
Brain Res.
(1993) - et al.
Characterization of axonally transported [125]PYY binding sites in rat vagus nerve
Brain Res.
(1991) - et al.
Blocking IL1: Interleukin1 receptor antagonist in vivo and in vitro
Immunol. Today
(1991) - et al.
Interleukin-1b induced corticosterone elevation and hypothalamic NE depletion is vagally mediated
Brain Res. Bull.
(1995) - et al.
Identification of a specific receptor for interleukin-1 in vascular smooth muscle cells: Regulation by interleukin-1 and interleukin-6
Eur. J. Pharmacol.
(1993) - et al.
Distribution and axonal relations of macrophages in a neuroma
Neuroscience
(1993) - et al.
Blockade of cytokine induced conditioned taste aversion by subdiaphragmatic vagotomy: Further evidence for vagal mediation of immune-brain communication
Neurosci. Lett.
(1995) Biological basis of the behavior of sick animals. Neurosci
Biobehav. Rev.
(1988)
A versatile means of intracellular labelling: Injection of biocytin and its detection with avidin conjugates
J. Neurosci. Methods
Sickness behavior as a new target for drug development
Trends Pharmacol. Sci.
The effects of lithium chloride on the activity of the afferent nerve fibers from the abdominal visceral organs in the rat
Brain Res. Bull.
Immobilization chemistries suitable for use in the BIAcore surface plasmon resonance detector
Anal. Biochem.
Anatomical considerations for surgery of the rat abdominal vagus: Distribution, paraganglia and regeneration
J. Auton. Nerv. Syst.
Blockade of lipopolysaccharide-induced fever by subdiaphragmatic vagotomy in guinea pigs
Brain Res.
Type I interleukin-1 receptors in the mouse brain-endocrine-immune axis labelled with [125I]recombinant human interleukin-1 receptor antagonist
J. Neuroimmunol.
Species differences in [125I]interleukin-1 binding in brain, endocrine and immune tissues
Brain Res.
Neural and biochemical mediators of endotoxin and stress-induced c-fos expression in the rat brain
Brain Res. Bull.
Cytokine-to-brain communication: A review and analysis
Life Sci.
Neurocircuitry of illness-induced hyperalgesia
Brain Res.
Characterization of cytokine-induced hyperalgesia
Brain Res.
Vagal afferent innervation of rat abdominal paraganglia as revealed by anterograde DiI-tracing and confocal microscopy
Acta Anat.
Characterization of vagal innervation to the rat celiac, suprarenal and mesenteric ganglia
J. Auton. Nerv. Syst.
An anterograde tracing study of the vagal innervation of rat liver, portal vein and biliary system
Anat. Embryol.
Identification of a common class of high affinity receptors for both types of porcine interleukin-1 on connective tissue cells
Nature
The immune system as a sensory organ
J. Immunol.
A complete regulatory loop between the immune and neuroendocrine systems
Fed. Proc.
Lipolysaccharide induces sickness behaviour in rats by a vagal mediated mechanism
C. R. Acad. Sci. Paris
Endotoxin and lung injury
Am. Rev. Respir. Dis.
Recent advances in the knowledge concerning chemodectomas
Lab. Invest.
Cited by (265)
Hepatic interoception in health and disease
2024, Autonomic Neuroscience: Basic and ClinicalVagus nerve stimulation as immunomodulatory therapy for stroke: A comprehensive review
2024, Experimental NeurologyThe role of microglia and monocytes in the generation and resolution of the immune response in female and male rats
2023, Brain, Behavior, and ImmunityThe cephalic phase of insulin release is modulated by IL-1β
2022, Cell MetabolismGut barrier dysfunction and type 2 immunity: Implications for compulsive behavior
2022, Medical Hypotheses